Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease

NCT05650229 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Mitochondrial Disease

Interventions

DRUG: KL1333
DRUG: Placebo

Sponsor

Abliva AB